NASDAQ: KBIO       Kalobios Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
Average Price Target:-


No recent Headlines for this stock.

Business Background

KaloBios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development of monoclonal antibody therapeutics for diseases that represent a burden to society and to patients and their families. The Company operates through the development of pharmaceutical products segment. The Company seeks to identify and develop products that may treat multiple indications through proof of concept studies. The Company's principal pharmaceutical product candidates include: KB004, KB003 and KB001‑A. KB004 is a Humaneered anti EphA3 monoclonal antibody that has the potential to offer an approach to treating both hematologic malignancies and solid tumors. KB003 is a Humaneered anti granulocyte macrophage colony stimulating factor monoclonal antibody that was developed for the treatment of severe asthma. KB001-A is a Humaneered, PEGylated, anti PcrV modified antibody fragment antibody that was developed for the prevention and treatment of Pseudomonas aeruginosa infections.

  kent323 likes this.
makubex718 4000% up
24/11/2015 20:34


3035  4442  466  613 

Top 10 Active Counters
 FB 162.67-9.89 
 GE 13.675-0.395 
 NVCN 0.112-0.012 
 TWTR 30.96-4.02 
 ORCL 47.13-4.82 
 AMD 11.155-0.275 
 ENRJ 0.393+0.102 
 EEM 49.17+0.49 
 MU 60.94+0.80 
 SPY 270.41-0.08 
Partners & Brokers